Dravet Syndrome
📧 Sign up to get email alerts when something new happens for Dravet Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies [Phase 2]
Phase 2 trial in pediatric epilepsy evaluating TAK-935 as adjunctive therapy; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome [Phase 3]
Phase 3 trial update investigating the cognitive effects of cannabidiol in Dravet Syndrome and Lennox-Gastaut Syndrome.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome [Phase 3]
A Phase 3 trial evaluating cannabidiol (GWP42003-P) in children and young adults with Dravet syndrome has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) [Phase 3]
Phase 3 trial update on GWP42003-P in children and young adults with Dravet syndrome. Completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) [Phase 2]
Phase 2 dose-ranging pharmacokinetics and safety study of GWP42003-P in children with Dravet syndrome completed; results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome [Phase 3]
A Phase 3 trial evaluated the safety and tolerability of adjunctive clobazam in pediatric patients with Dravet syndrome. The study was termi…